CD274 and cancer: With this apparent difference in affinities, supported by both molecular mechanics and molecular dynamics simulation, Compound 5 could be a potential hit in the search for a drug that would selectively inhibit PD-L1 in cancer microenvironment pH conditions while interacting significantly less with this protein at a normal physiological pH.